ask="10.54"
ask_size="200"
average_daily_volume="259938"
bid="9.75"
bid_size="100"
book_value="2.66"
change="+0.18"
change_from_200_day_moving_average="1.22"
change_from_50_day_moving_average="0.27"
change_from_52_week_high="-0.87"
change_From_52_week_low="3.20"
change_in_percent="+1.80%"
close="10.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.03"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.73"
ex_dividend_date="N/A"
float_shares="14471000"
high="10.25"
high_52_weeks="11.07"
last_trade_date="3/1/2017"
last_trade_price="10.20"
last_trade_size="12125"
last_trade_time="4:00pm"
low="9.94"
low_52_weeks="7.00"
market_capitalization="186.66M"
moving_average_200_day="8.98"
moving_average_50_day="9.93"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="10.18"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+13.54%"
percent_change_from_50_day_moving_average="+2.73%"
percent_change_from_52_week_high="-7.86%"
percent_change_from_52_week_low="+45.71%"
previous_close="10.02"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.77"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="7.05"
stock_exchange="NGM"
symbol="AKBA"
volume="232574"
weeks_range_52="7.00 - 11.07"
